182 related articles for article (PubMed ID: 6120656)
1. The coexistence of parkinsonism-like symptoms and tardive dyskinesia.
Richardson MA; Craig TJ
Am J Psychiatry; 1982 Mar; 139(3):341-3. PubMed ID: 6120656
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
Bitton V; Melamed E
J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
Hansen TE; Brown WL; Weigel RM; Casey DE
J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
[TBL] [Abstract][Full Text] [Related]
4. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
[TBL] [Abstract][Full Text] [Related]
5. Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia.
Caligiuri MP; Lohr JB; Bracha HS; Jeste DV
Biol Psychiatry; 1991 Jan; 29(2):139-48. PubMed ID: 1671645
[TBL] [Abstract][Full Text] [Related]
6. Vulnerability to tardive dyskinesia.
Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
[TBL] [Abstract][Full Text] [Related]
7. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
Brown KW; White T
Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical findings in the cerebrospinal fluid of schizophrenic patients with tardive dyskinesia and neuroleptic-induced parkinsonism.
Saito T; Ishizawa H; Tsuchiya F; Ozawa H; Takahata N
Jpn J Psychiatry Neurol; 1986 Jun; 40(2):189-94. PubMed ID: 2431183
[TBL] [Abstract][Full Text] [Related]
9. Coexisting tardive dyskinesia and parkinsonian symptoms.
Goetz CG
Am J Psychiatry; 1982 Nov; 139(11):1526-7. PubMed ID: 6127959
[No Abstract] [Full Text] [Related]
10. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
Brown KW; White T
Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
[TBL] [Abstract][Full Text] [Related]
11. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
[TBL] [Abstract][Full Text] [Related]
12. Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?
Melamed E; Achiron A; Shapira A; Davidovicz S
Clin Neuropharmacol; 1991 Jun; 14(3):273-8. PubMed ID: 1676933
[TBL] [Abstract][Full Text] [Related]
13. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
Shoulson I
Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
[No Abstract] [Full Text] [Related]
14. Tardive dyskinesia and positive symptoms of schizophrenia.
White T; Brown KW; Woods JP
Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Ghadirian AM; Annable L; Bélanger MC; Chouinard G
J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
[TBL] [Abstract][Full Text] [Related]
16. Episodic tardive dyskinesia and parkinsonism in bipolar disorder patients.
Scappa S; Teverbaugh P; Ananth J
Can J Psychiatry; 1993 Dec; 38(10):633-4. PubMed ID: 7906192
[TBL] [Abstract][Full Text] [Related]
17. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
Lohr JB; Caligiuri MP
J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
Richardson MA; Haugland G; Craig TJ
Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
Sandyk R; Kay SR
Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
